Schizophrenia is not associated with the functional candidate gene ERBB3: Results from a case-control study

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 144, Issue 1, 2007, Pages 113-116

  Kanazawa, Tetsufumi ^a,b   Glatt, Stephen J ^a,c   Tsutsumi, Atsushi ^b   Kikuyama, Hiroki ^b   Koh, Jun ^b   Yoneda, Hiroshi ^b   Tsuang, Ming T ^a,c,d,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OSAKA MEDICAL COLLEGE   (Japan)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d HARVARD UNIVERSITY   (United States)

^e VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Association; Case control; ERBB3; Gene; Myelin; Schizophrenia

Indexed keywords

ADULT; ARTICLE; BRAIN CORTEX; CASE CONTROL STUDY; CONTROLLED STUDY; ERBB3 GENE; FEMALE; FUNCTIONAL GENOMICS; GENE; GENE CONTROL; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MYELINATION; NRG1 GENE; ONSET AGE; PRIORITY JOURNAL; REGULATOR GENE; REGULATORY MECHANISM; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; ALLELES; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA PRIMERS; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENES, ERBB; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 33846291021     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30367     Document Type: Article

References (13)

1. Aston C, Jiang L, Sokolov BP. 2004. Microarray analysis of postmortem temporal cortex from patients with schizophrenia. J Neurosc Res 77(6): 858-866.
2. Bartzokis G. 2002. Schizophrenia: Breakdown in the well-regulated lifelong process of brain development and maturation. Neuropsychopharmacol 27(4):672-683.
3. Corfas G, Roy K, Buxbaum JD. 2004. Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nat Neurosci 7(6):575-580.
4. Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, Hof PR, Buxbaum J, Haroutunian V. 2003. White matter changes in schizophrenia: Evidence for myelin-related dysfunction. Arch Gen Psychiatry 60(5):443-456.
5. DeLisi LE. 1997. Is schizophrenia a lifetime disorder of brain plasticity, growth and aging? Schizophr Res 23(2):119-129.
6. Duan J, Martinez M, Sanders AR, Hou C, Krasner AJ, Schwartz DB, Gejman PV. 2005. Neuregulin 1 (NEG1) and schizophrenia: Analysis of a US family sample and the evidence in the balance. Psychol Med 35(11): 1599-1610.
7. Foong J, Maier M, Barker GJ, Brocklehurst S, Miller DH, Ron MA. 2000. In vivo investigation of white matter pathology in schizophrenia with magnetisation transfer imaging. J Neurol Neurosurg Psychiatry 68(1): 70-74.
8. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, Haroutunian V, Fienberg AA. 2001. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 98(8):4746-4751.
9. Rapoport JL, Addington AM, Frangou S, Psych MR. 2005. The neurodevelopmental model of schizophrenia: Update 2005. Mol Psychiatry 10(5):434-449.
10. Sham PC, Cherny SS, Purcell S, Hewitt JK. 2000. Power of linkage versus association analysis of quantitative traits, by use of variance-components models, for sibship data. Am J Hum Genet 66(5):1616-1630.
11. Singh SM, McDonald P, Murphy B, O'Reilly R. 2004. Incidental neurodevelopmental episodes in the etiology of schizophrenia: An expanded model involving epigenetics and development. Clin Genet 65(6): 435-440.
12. Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB, Starkey M, Webster MJ, Yolken RH, Bahn S. 2003. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362(9386): 798-805.
13. Weinberger DR. 1987. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44(7):660-669.